3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Genitourinary
1
CNS
1
Conditions
Prostatic Neoplasms
6
Breast Neoplasms
3
Pancreatic Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pain
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Interventions
Filgrastim
10
Cyclophosphamide
8
Granulocyte Colony-Stimulating Factor
6
Melphalan
5
Busulfan
5
Vincristine
4
Topotecan
4
Temozolomide
4
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Ifosfamide
4
Etoposide
4
Thiotepa
3
Radiotherapy
3
Mesna
3
Itraconazole
3
Doxorubicin
3
Cisplatin
3
Carboplatin
3
sargramostim
2
fludarabine
2
Therapeutics
2
Sirolimus
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Drug Therapy
2
Bone Marrow Transplantation
2
Blood Specimen Collection
2
Amplified Fragment Length Polymorphism Analysis
2
trioctyl phosphine oxide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Wilms Tumor
×
Genistein
×
Clear all
NCT02624388
2024-05-06
UVA-Gen001
University of Virginia
Phase 2
Terminated
4 enrolled
16 charts